Innovations for Heart and Vessels has conducted several publically finded projects - five projects related to patents in the field of cardiovascular interventions as well as three large research projects for which the details are provided below.


InFlow - Development and implementation of the first Polish transcatheter low-profile aortic valve.

Project consortium members: American Heart of Poland Inc. (Leader), Balton Ltd., Silesian Center for Heart Diseases, Centre of Polymer and Carbon Materials Sciences, Silesian University of Technology, National Research Institute of Animal Production, Innovations for Heart and Vessels Ltd.

The aim of the project is to create a new generation low-profile, balloon-expandable and self-positioning transcatheter aortic valve “InFlow” by using new composite and biological materials.

Total budget:
eligible costs 14.8 million PLN
funding 11.6 million PLN


Apollo - Development and comprehensive evaluation of the first Polish, second generation, thin strut biodegradable polymer and elastic, Sirolimus eluting vascular stent.

Project consortium members: American Heart of Poland Inc. (consortium leader), Balton Ltd., Centre of Polymer and Carbon Materials of the Polish Academy of Sciences, Silesian University of Technology Faculty of Biomedical Engineering, Silesian Center for Heart Diseases, Military University of Technology, Innovations for Heart and Vessels Ltd.

The aim of the project is the development and preclinical evaluation of new thin-strut biodegradable sirolimus eluting stent (PBES) as well as to verify its usefulness and therapeutic use in a preclinical studies.

Total budget:
eligible costs 14.31 million PLN
funding 11.45 million PLN


BSM STENT - Development of self-expanding, polymeric and biodegradable, drug-eluting vascular stents.

Project consortium members: Centre of Polymer and Carbon Materials of the Polish Academy of Sciences (leader), American Heart of Poland Inc., Innovations for Heart and Vessels Ltd.

The aim of the project is to produce a working prototype of bioresorbable, self-expanded, drug-eluting intravascular stents with shape memory behaviour, using an innovative micro-injection technique. 

Total budget:
eligible costs 4.75 million PLN
funding 3.94 million PLN


ENLogopng